- Active not recruitingPHASE3
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
This study looks at a new epilepsy medicine, ZX008 (fenfluramine), for children and adults aged 1 to 35 with CDKL5 Deficiency Disorder (CDD). It aims to see if it helps reduce seizures and if it's safe for people whose seizures haven't improved with other treatments.
For: CDKL5 Deficiency Disorder · Generalized Tonic Clonic Seizure · Epileptic SpasmUnited States · Austria · Belgium - Active not recruitingPHASE3
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
This study is looking at a medicine called fenfluramine in very young children (aged 1 to just under 2 years old) with a rare type of epilepsy called Dravet syndrome. It aims to check if the medicine is safe and well-tolerated at different doses.
For: Dravet SyndromeUnited States · Belgium · Germany